Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
New York, NY, May 07, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled “B-Cell Maturation Antigen (BCMA) Targeted Therapies Market by Product Type (CAR-T cell,...
-
Dublin, May 07, 2021 (GLOBE NEWSWIRE) -- The "Men's Personal Care Market Size, Share & Trends Analysis Report by Product (Skincare, Personal Grooming), by Distribution Channel (Hypermarket &...
-
ATLANTA and HOUSTON, May 07, 2021 (GLOBE NEWSWIRE) -- Chart Industries, Inc. (“Chart”) (NYSE: GTLS), a leading diversified global manufacturer of highly engineered equipment for the industrial gas...
-
NEW YORK and SAN DIEGO, May 07, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce”), which has entered into an agreement for a business combination with Leisure Acquisition Corp. (“LACQ”)...
-
Study will evaluate safety and immunogenicity of oral norovirus vaccine in elderly population Norovirus represents a significant unmet need in the elderly — there currently is no approved vaccine ...
-
FORT LAUDERDALE, Fla., May 07, 2021 (GLOBE NEWSWIRE) -- 6 Solutions, a housing and banking data startup transforming how banks and lenders make strategic growth decisions, today appointed Jeff...
-
ADDISON, Texas, May 07, 2021 (GLOBE NEWSWIRE) -- Daseke, Inc. (NASDAQ: DSKE) (“Daseke” or the “Company”), the largest flatbed, specialized transportation and logistics solutions company in North...
-
Patient enrollment and dosing in the Phase 1/2 clinical trial of BDTX-189 continue to track in line with projections at initiation of the study, with dose-escalation portion on track to complete in...
-
TORONTO, May 07, 2021 (GLOBE NEWSWIRE) -- O2Gold Inc. (“O2Gold” or the “Company”) (TSXV: OTGO) is pleased to announce the first results of its work on the properties acquired from Grupo de Bullet...
-
BOSTON, May 07, 2021 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a rare disease biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization,...